These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 3566832)
1. Potentiation of the locomotor activity of memantine by aminophylline. Youssif N; Ammon HP Arzneimittelforschung; 1986 Dec; 36(12):1717-20. PubMed ID: 3566832 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacodynamics and pharmacokinetics of memantine]. Wesemann W; Sontag KH; Maj J Arzneimittelforschung; 1983; 33(8):1122-34. PubMed ID: 6357202 [TBL] [Abstract][Full Text] [Related]
3. [The Effect of memantine on spinal alpha-motoneurons and on the content of dopamine, noradrenaline and serotonin in the striatum and lumbar spinal cord]. Sontag KH; Wand P; Schwarz M; Wesemann W; Osborne NN Arzneimittelforschung; 1982; 32(10):1236-40. PubMed ID: 6891222 [TBL] [Abstract][Full Text] [Related]
4. The influence of memantine on the anticonvulsant effects of the antiepileptic drugs. Chojnacka-Wójcik E; Tatarczyńska E; Maj J Pol J Pharmacol Pharm; 1983; 35(6):511-5. PubMed ID: 6429651 [TBL] [Abstract][Full Text] [Related]
5. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration. Fredriksson A; Archer T Amino Acids; 2002; 23(1-3):111-32. PubMed ID: 12373526 [TBL] [Abstract][Full Text] [Related]
6. [Effect of memantine on central neurotransmitter systems. Review of the results]. Maj J Arzneimittelforschung; 1982; 32(10):1256-9. PubMed ID: 6129854 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of jumping behavior by aminophylline in mice treated with threshold doses of amphentamine and dopa. Colpaert FC; Lal H Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):587-90. PubMed ID: 4445575 [No Abstract] [Full Text] [Related]
8. Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder. Egashira N; Okuno R; Harada S; Matsushita M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M Eur J Pharmacol; 2008 May; 586(1-3):164-70. PubMed ID: 18423440 [TBL] [Abstract][Full Text] [Related]
9. Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats. Skuza G; Rogoz Z; Quack G; Danysz W J Neural Transm Gen Sect; 1994; 98(1):57-67. PubMed ID: 7710739 [TBL] [Abstract][Full Text] [Related]
10. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization. David HN; Ansseau M; Lemaire M; Abraini JH Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030 [TBL] [Abstract][Full Text] [Related]
11. The effect of memantine on various neurobiological processes. Osborne NN; Beale R; Golombiowska-Nikitin K; Sontag KH Arzneimittelforschung; 1982; 32(10):1246-55. PubMed ID: 6185123 [TBL] [Abstract][Full Text] [Related]
12. [The effect of memantine (dimethylamino-adamantane) on membranes of sensory nerve fibres (author's transl)]. Grossmann W; Jurna I Arzneimittelforschung; 1977 Jul; 27(7):1483-7. PubMed ID: 578479 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological evidence for the involvement of GABA-ergic system in the locomotor stimulation produced in mice by 1,3-dimethyl-5-aminoadamantane (D-145). Menon MK; Clark WG Neuropharmacology; 1978 Dec; 17(12):1049-52. PubMed ID: 745691 [No Abstract] [Full Text] [Related]
14. GABA-ergic drugs block the locomotor stimulant effects of 1,3-dimethyl-5-aminoadamantane (D-145). Menon MK; Clark WG Neuropharmacology; 1979 Feb; 18(2):223-5. PubMed ID: 431791 [No Abstract] [Full Text] [Related]
15. [Circadian rhythm of mortality, spontaneous locomotor activity, and LD50 following application of 1,1,2,2,-tetrabromoethane alone and in combination with ethanol]. Wolff DL Acta Biol Med Ger; 1982; 41(10):945-52. PubMed ID: 7170866 [TBL] [Abstract][Full Text] [Related]
16. Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. Minkeviciene R; Banerjee P; Tanila H J Pharmacol Exp Ther; 2004 Nov; 311(2):677-82. PubMed ID: 15192085 [TBL] [Abstract][Full Text] [Related]
17. Caffeine withdrawal syndrome in social interaction test in mice: effects of the NMDA receptor channel blockers, memantine and neramexane. Sukhotina IA; Zvartau EE; Danysz W; Bespalov AY Behav Pharmacol; 2004 May; 15(3):207-14. PubMed ID: 15187578 [TBL] [Abstract][Full Text] [Related]